Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-08-01
2006-08-01
Siew, Jeffrey (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100, C536S023500
Reexamination Certificate
active
07083927
ABSTRACT:
An isolated nucleic acid molecule mapping to chromosome 16q24.3 and comprising the nucleotide sequence set forth in SEQ ID Numbers: 1 or 3.
REFERENCES:
patent: 6569662 (2003-05-01), Tang et al.
patent: WO 01/53312 (2001-07-01), None
patent: 02/081514 (2002-10-01), None
patent: 02/103320 (2002-12-01), None
patent: 03/012103 (2003-02-01), None
Protein Identification Resource database (National Biomedical Research Foundation, Washington, DC, Accession No. T17239, 1999).
Baumeister et al., “The Proteasome: Paradigm of a Self-Compartmentalizing Protease,”Cell, 92:367-380 (Feb. 6, 1998).
Brenner et al., “Chromosome 9p Allelic Loss andp. 16/CDKN2in Breast Cancer and Evidence ofp/16Inactivation in Immortal Breast Epithelial Cells,”Cancer Research, 55:2892-2895 (Jul. 1, 1995).
Cenciarelli et al., “Identification of a family of human F-box proteins,”Current Biology, 9(20):1177-1179 (Oct. 11, 1999).
Chen et al., “Delection Map of Chromosome 16q in Ductal Carcinomain Situof the Breast: Refining a Putative Tumor Suppressor Gene Region,”Cancer Research, 56:5605-5609 (Dec. 15, 1996).
Cleton-Jansen et al., “Loss of heterozygosity in sporadic breast tumours at theBRCA2locus on chromosome 13q12-q13,”British Journal of Cancer, 72:1241-1244 (1995).
Cockman et al., “Hyposia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein,”Journal of Biological Chemistry, 275(33):25733-25741 (Aug. 18, 2000).
Devilee et al., “Somatic genetic changes in human breast cancer,”Biochimica et Biophysica Acta, 1198:113-130 (1994).
Esteller et al., “Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors,”Journal of the National Cancer Institute, 92(7):564-569 (Apr. 5, 2000).
Fearon et al., “A Genetic Model for Colorectal Tumorigenesis,”Cell, 61:759-767 (Jun. 1, 1990).
Futreal et al., “BRCA1Mutations in Primary Breast and Ovarian Carcinomas,”Science, 266: (Oct. 7, 1994).
Haas et al., “Pathways of ubiquitin conjugation,”FASEB J., 11:1257-1268 (1997).
Hall et al., “Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21,”Science, 250:1684-1689 (Dec. 21, 1990).
Herman et al., “Incidence and functional consequences ofhMLH1promoter hypermethylation in colorectal carcinoma,”Proc. Natl. Acad. Sci. USA, 95:6870-6875 (Jun. 1998).
Hershko et al., “The Ubiquitin System,”Annu. Rev. Biochem., 67:425-479 (1998).
Kipreos et al., “The F-box protein family,”Genome Biology, 1(5):3002.1-3002.7 (Nov. 10, 2000).
Li et al., “Ubiquitination of A Novel Deubiquitinating Enzyme Requires Direct Binding to von Hippel-Lindau Tumor Suppressor Protein,”Am. Soc. for Biochem. and Molecu. Bio., pp. 1-22 (Dec. 5, 2001).
Lopez Salon et al., “Defective Ubiquitination of Cerebral Proteins in Alzheimer's Disease,”Journal of Neuroscience Research, 63:302-310 (2000).
Miki et al., “A Strong Candidate for the Breast and Ovarian Cancer Susceptibility GeneBRCA1,”Science, 266:66-71 (Oct. 7, 1994).
Miki et al., “Mutation analysis in theBRCA2igene in primary breast cancers,”Nature Genetics, 13:245-247 (Jun. 1996).
Ohh et al., “Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein,”Nature Cell Biology, 2:423-427 (Jul. 2000).
Ohtani-Fujita et al., “Hypermethylation in the Retinoblastoma Gene Is Associated with Unilateral, Sporadic Retinoblastoma,”Cancer Genet Cytogenet, 98:43-49 (1997).
Peters, “SCF and APC: the Yin and Yang of cell cycle regulated proteolysis,”Current Opinion in Cell Biology, 10:759-768 (1998).
Powell et al., “Sequencing, Transcript Indentification, and Quantitive Gene Expression Profiling in the Breast Cancer Loss of Heterozygosity Region 16q24.3 Reveal Three Potential Tumor Suppressor Genes,”Genomics, 80(3):303-310 (Sep. 2002).
Prowse et al., “Somatic Inactivation of the VHL Gene in Von Hippel-Lindau Disease Tumors,”Am. J. Hum. Genet., 60:765-771 (1997).
Radford et al., “Allelotyping of Ductal Carcinomain Situof the Breast: Deletion of Loci on 8p, 13q, 16q, 17p and 17q,”Cancer Research, 55:3399-3405 (Aug. 1, 1995).
Saito et al., “Detailed Deletion Mapping of Chromosome 17q in Ovarian and Breast Cancers: 2-cM Region on 17q21.3 Often and Commonly Deleted in Tumors,”Cancer Research, 53:3382-3385 (Jul. 15, 1993).
Semenza, “HIF-1 and human disease: one highly involved factor,”Genes&Development, 14:1983-1991 (2000).
Shimura et al., “Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease,”Science, 293:263-269 (Jul. 13, 2001).
van 't Veer et al., “Gene expression profiling clinical outcome of breast cancer,”Nature, 415:530-536 (Jan. 31, 2002).
Wang et al., “Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2tension,”Proc. Natl. Acad. Sci. USA, 92:5510-5514 (Jun. 1995).
Winston et al., “A family of mammalian F-box proteins,”Current Biology, 9:1180-1182 (Oct. 11, 1999).
Wooster et al., “Localization of a Breast Cancer Susceptibility Gene,BRCA2, Chromosome 13q12-13,”Science, 265:2088-2090 (Sep. 30. 1994).
Wooster et al., “Identification of the breast cancer susceptibility geneBRCA2,” Nature, 378(21):789-792 (Dec. 28, 1995).
Koehrer K. et al., “Homo sapiens mRNA; cDNA DKFZp434B027 (from clone DKFZp434B027”,GenPeptdatabase Accession No. CAB55929; Sep. 15, 1999.
Koehrer K. et al., “Hypothetical protein DKFZp434B027.1-human (fragment)”;PIRdatabase Accession No. T17239; Oct. 15, 1999.
EMBLdatabase Accession No. AL117444.
Strausberg, R., “Homo sapiens, clone MGC:15419 IMAGE: 3958783, mRNA”,GenPeptdatabase Accession No. AAH12748 &GenBankdatabase Accession No. BC012748; Sep. 20, 2001.
Zhou, et al.; “Homo sapiens pp2386 mRNA”;GenPeptdatabase Accession No. AAL55855 &GenBankdatabase Accession No. AF318348; Jan. 1, 2002.
Osada et al., Mus musculus brain cDNA, clone MNCb-2609, similar to Homo sapiens mRNA; cDNA DKFZp434B027 (from clone DKFZp434B027),GenPeptdatabase Accession No. BAA95069 &EMBLdatabase Accession No. AB041586; Apr. 30, 2000.
International for Corresponding PCT Appl. No. PCT/AU02/00096 dated Mar. 22, 2002.
Supplementary Search Report from the European Patent Office for corresponding European application 02 71 1634 dated Apr. 1, 2004.
Drobnjak, et al.,Altered Expression of p27 and Skp2 Proteins in Prostate Cancer of African-American Patients, Clinical Cancer Research9:263-2619 (Jul. 2003).
Bais Anthony
Callen David Frederick
Crawford Joanna
Gardner Alison
Kochetkova Marina
Bionomics Limited
Fetterolf Brandon
Siew Jeffrey
LandOfFree
Gene BN01 mapping to chromosome 16q24.3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene BN01 mapping to chromosome 16q24.3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene BN01 mapping to chromosome 16q24.3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3711091